We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

114 hedge funds and large institutions have $701M invested in NxStage Medical Inc. in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,689% more call options, than puts

Call options by funds: $2.18M | Put options by funds: $28K

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

30% more capital invested

Capital invested by funds: $541M → $701M (+$161M)

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

0% more funds holding

Funds holding: 114114 (0)

30% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 44

Holders
114
Holders Change
Holders Change %
0%
% of All Funds
3.29%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
21
Increased
31
Reduced
44
Closed
19
Calls
$2.18M
Puts
$28K
Net Calls
+$2.15M
Net Calls Change
+$1.91M
Name Holding Trade Value Shares
Change
Change in
Stake
WI
26
WHV Investments
California
$8.13M -$21.4M -1,641,585 -72%
PP
27
Paloma Partners
Connecticut
$6.95M -$2.02M -154,645 -22%
N
28
Nuveen
North Carolina
$6.92M +$5.16M +395,752 +268%
SAM
29
Sectoral Asset Management
Quebec, Canada
$6.33M -$3.35M -256,969 -34%
DCM
30
DAFNA Capital Management
California
$4.89M
Norges Bank
31
Norges Bank
Norway
$4.87M -$13.6M -1,043,259 -73%
WMSA
32
Weiss Multi-Strategy Advisers
New York
$4.27M -$783K -60,000 -15%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$3.88M +$356K +27,296 +10%
VAM
34
Visium Asset Management
New York
$3.83M +$3.92M +300,800 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.8M +$4.96K +380 +0.1%
Ameriprise
36
Ameriprise
Minnesota
$3.65M +$2.42M +185,560 +183%
OAM
37
Oxford Asset Management
United Kingdom
$3.34M +$3.42M +261,976 New
TCIM
38
TIAA CREF Investment Management
New York
$2.94M -$162K -12,388 -5%
BCM
39
BBT Capital Management
Texas
$2.87M -$2.31M -176,879 -44%
CAD
40
Craig A. Drill
$2.72M +$2.79M +213,800 New
HPCM
41
High Pointe Capital Management
Illinois
$2.72M
ERSOT
42
Employees Retirement System of Texas
Texas
$2.52M
CCP
43
Clough Capital Partners
Massachusetts
$2.45M -$6.09M -466,700 -71%
FLAM
44
First Light Asset Management
Minnesota
$2.24M +$2.29M +175,655 New
BIM
45
BlackRock Investment Management
Delaware
$2.11M +$18.4K +1,408 +0.9%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$2.08M -$1.17M -90,000 -36%
Charles Schwab
47
Charles Schwab
California
$2.03M +$53.1K +4,074 +3%
MAA
48
Managed Account Advisors
New Jersey
$2M +$188K +14,394 +10%
ICAP
49
Independence Capital Asset Partners
Colorado
$1.95M +$1.99M +152,651 New
CA
50
Continental Advisors
Utah
$1.76M -$170K -13,000 -9%

NXTM Hedge Fund Activity: Q1 2014 in Review

114 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2014, worth a combined $701M — up 30% from $541M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NXTM positions and 19 closed out — a net gain of 2 holders — while 31 added to existing stakes and 44 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $56M. The largest seller was Deerfield Management, cutting an estimated $23.1M.

  • 114 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $701M of NxStage Medical Inc. stock for Q1 2014, up 30% quarter-over-quarter.
  • 21 funds opened new NxStage Medical Inc. positions in Q1 2014 and 19 closed out, a net change of +2 holders.
  • The largest NxStage Medical Inc. buyer in Q1 2014 was Gilder Gagnon Howe & Co, an estimated $56M added.
  • The largest NxStage Medical Inc. seller in Q1 2014 was Deerfield Management, an estimated $23.1M sold.

Based on aggregated 13F filings for Q1 2014.